Search research articles
Contact Us
Filters
Showing results (21-30 of 32) with videos related to
Page
of 4
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 10, 2017
Management of an Outbreak of Exophiala dermatitidis Bloodstream Infections at an Outpatient Oncology Clinic
Amber Vasquez, D Zavasky, N A Chow, et al.
Journal of Clinical Microbiology
|
August 17, 1999
Elucidating the origins of nosocomial infections with Candida albicans by DNA fingerprinting with the complex probe Ca3
F Marco, S R Lockhart, M A Pfaller, et al.
Antimicrobial Agents and Chemotherapy
|
November 27, 2013
Multicenter study of anidulafungin and micafungin MIC distributions and epidemiological cutoff values for eight Candida species and the CLSI M27-A3 broth microdilution method
M A Pfaller, A Espinel-Ingroff, B Bustamante, et al.
Journal of Clinical Microbiology
|
January 24, 2024
Genomic description of acquired fluconazole- and echinocandin-resistance in patients with serial <i>Candida glabrata</i> isolates
E Misas, E Seagle, E N Jenkins, et al.
Journal of Clinical Microbiology
|
May 22, 2024
Erratum for Misas et al., "Genomic description of acquired fluconazole- and echinocandin-resistance in patients with serial <i>Candida glabrata</i> isolates"
E Misas, E Seagle, E N Jenkins, et al.
Journal of Clinical Microbiology
|
March 31, 2012
Wild-type MIC distributions and epidemiological cutoff values for amphotericin B, flucytosine, and itraconazole and Candida spp. as determined by CLSI broth microdilution
M A Pfaller, A Espinel-Ingroff, E Canton, et al.
Antimicrobial Agents and Chemotherapy
|
January 15, 2014
Multilaboratory study of epidemiological cutoff values for detection of resistance in eight Candida species to fluconazole, posaconazole, and voriconazole
A Espinel-Ingroff, M A Pfaller, B Bustamante, et al.
Antimicrobial Agents and Chemotherapy
|
March 7, 2012
Cryptococcus neoformans-Cryptococcus gattii species complex: an international study of wild-type susceptibility endpoint distributions and epidemiological cutoff values for amphotericin B and flucytosine
A Espinel-Ingroff, A Chowdhary, M Cuenca-Estrella, et al.
Antimicrobial Agents and Chemotherapy
|
September 11, 2013
Interlaboratory variability of Caspofungin MICs for Candida spp. Using CLSI and EUCAST methods: should the clinical laboratory be testing this agent?
A Espinel-Ingroff, M C Arendrup, M A Pfaller, et al.
Antimicrobial Agents and Chemotherapy
|
September 6, 2012
Cryptococcus neoformans-Cryptococcus gattii species complex: an international study of wild-type susceptibility endpoint distributions and epidemiological cutoff values for fluconazole, itraconazole, posaconazole, and voriconazole
A Espinel-Ingroff, A I Aller, E Canton, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 32) with videos related to
Sort By:
Page
of 4
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 10, 2017
Management of an Outbreak of Exophiala dermatitidis Bloodstream Infections at an Outpatient Oncology Clinic
Amber Vasquez, D Zavasky, N A Chow, et al.
Journal of Clinical Microbiology
|
August 17, 1999
Elucidating the origins of nosocomial infections with Candida albicans by DNA fingerprinting with the complex probe Ca3
F Marco, S R Lockhart, M A Pfaller, et al.
Antimicrobial Agents and Chemotherapy
|
November 27, 2013
Multicenter study of anidulafungin and micafungin MIC distributions and epidemiological cutoff values for eight Candida species and the CLSI M27-A3 broth microdilution method
M A Pfaller, A Espinel-Ingroff, B Bustamante, et al.
Journal of Clinical Microbiology
|
January 24, 2024
Genomic description of acquired fluconazole- and echinocandin-resistance in patients with serial <i>Candida glabrata</i> isolates
E Misas, E Seagle, E N Jenkins, et al.
Journal of Clinical Microbiology
|
May 22, 2024
Erratum for Misas et al., "Genomic description of acquired fluconazole- and echinocandin-resistance in patients with serial <i>Candida glabrata</i> isolates"
E Misas, E Seagle, E N Jenkins, et al.
Journal of Clinical Microbiology
|
March 31, 2012
Wild-type MIC distributions and epidemiological cutoff values for amphotericin B, flucytosine, and itraconazole and Candida spp. as determined by CLSI broth microdilution
M A Pfaller, A Espinel-Ingroff, E Canton, et al.
Antimicrobial Agents and Chemotherapy
|
January 15, 2014
Multilaboratory study of epidemiological cutoff values for detection of resistance in eight Candida species to fluconazole, posaconazole, and voriconazole
A Espinel-Ingroff, M A Pfaller, B Bustamante, et al.
Antimicrobial Agents and Chemotherapy
|
March 7, 2012
Cryptococcus neoformans-Cryptococcus gattii species complex: an international study of wild-type susceptibility endpoint distributions and epidemiological cutoff values for amphotericin B and flucytosine
A Espinel-Ingroff, A Chowdhary, M Cuenca-Estrella, et al.
Antimicrobial Agents and Chemotherapy
|
September 11, 2013
Interlaboratory variability of Caspofungin MICs for Candida spp. Using CLSI and EUCAST methods: should the clinical laboratory be testing this agent?
A Espinel-Ingroff, M C Arendrup, M A Pfaller, et al.
Antimicrobial Agents and Chemotherapy
|
September 6, 2012
Cryptococcus neoformans-Cryptococcus gattii species complex: an international study of wild-type susceptibility endpoint distributions and epidemiological cutoff values for fluconazole, itraconazole, posaconazole, and voriconazole
A Espinel-Ingroff, A I Aller, E Canton, et al.
Page
of 4